Dr. Parinda A Mehta, MD
Claim this profileCincinnati Children's Hospital Medical Center
Studies Anemia
Studies Fanconi Anemia
5 reported clinical trials
5 drugs studied
Area of expertise
1Anemia
HLA positive
HLA negative
DEB
2Fanconi Anemia
HLA positive
HLA negative
DEB
Affiliated Hospitals
Clinical Trials Parinda A Mehta, MD is currently running
Alemtuzumab Dosing
for Bone Marrow Transplant
Alemtuzumab is an antibody that reduces the strength of the immune system that is given in preparation for allogeneic hematopoietic cell transplant (HCT). In this research study the investigators want to find out if they can adjust the dose of alemtuzumab used as part of allogeneic HCT to target the level of Day 0 (the planned day of graft infusion) to an optimal therapeutic window of 0.15-0.9 ug/mL.
Recruiting1 award Phase 2
Chemotherapy + Stem Cell Transplant
for Fanconi Anemia
The purpose of this study is to determine whether the use of lower doses of busulfan and the elimination of cyclosporine will further reduce transplant-related side effects for patients with Fanconi Anemia (FA). Patients will undergo a transplant utilizing mis-matched related or matched unrelated donors following a preparative regimen of busulfan, fludarabine, anti-thymocyte globulin and cyclophosphamide.
Recruiting1 award Phase 28 criteria
More about Parinda A Mehta, MD
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Parinda A Mehta, MD has experience with
- Quercetin
- Busulfan
- Cyclophosphamide
- TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
- Alemtuzumab
Breakdown of trials Parinda A Mehta, MD has run
Anemia
Fanconi Anemia
Renal Fanconi Syndrome
Bone Marrow Transplant
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Parinda A Mehta, MD specialize in?
Parinda A Mehta, MD focuses on Anemia and Fanconi Anemia. In particular, much of their work with Anemia has involved HLA positive patients, or patients who are HLA negative.
Is Parinda A Mehta, MD currently recruiting for clinical trials?
Yes, Parinda A Mehta, MD is currently recruiting for 2 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Parinda A Mehta, MD has studied deeply?
Yes, Parinda A Mehta, MD has studied treatments such as Quercetin, Busulfan, Cyclophosphamide.
What is the best way to schedule an appointment with Parinda A Mehta, MD?
Apply for one of the trials that Parinda A Mehta, MD is conducting.
What is the office address of Parinda A Mehta, MD?
The office of Parinda A Mehta, MD is located at: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229 United States. This is the address for their practice at the Cincinnati Children's Hospital Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.